Showing results (141-150 of 179) with videos related to
Sort By:
Pageof 18
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2009
Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response?Robert A Meguid, Craig M Hooker, Joshua T Taylor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitorE K Rowinsky, L B Grochow, C B Hendricks, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neckA S Garden, J Harris, E E Vokes, et al.Journal of the National Cancer Institute|June 19, 1996
Phase I and pharmacologic studies of topotecan in patients with impaired hepatic functionS O'Reilly, E Rowinsky, W Slichenmyer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependenceE K Rowinsky, S H Kaufmann, S D Baker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024David I Rosenthal, Jonathan Harris, Arlene A Forastiere, et al.Diagnostics (Basel, Switzerland)|November 13, 2025
The Value of Circulating Tumor HPV DNA in Head and Neck Squamous Cell Cancer: A ReviewRüveyda Dok, Sandra Nuyts, Fernando Lopez, et al.The New England Journal of Medicine|December 3, 2003
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancerArlene A Forastiere, Helmuth Goepfert, Moshe Maor, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2014
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)H J Wanebo, J Lee, B A Burtness, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck CancerAthanassios Argiris, Shuli Li, Panayiotis Savvides, et al.Pageof 18